NanoView Biosciences is developing proprietary products that support research, translation, and delivery of precision medicine. The Company was founded on a novel technology platform that uniquely identifies and characterizes exosomes. Its high-throughput, cost-effective analysis solutions enable life science, researchers, to better understand the biology of cellular communication and provide improved insight into how diseases are diagnosed, treated, and monitored. NanoView Biosciences was formed in 2015 and is based in Brighton, Massachusetts.
